Genzyme Pompe Program Update—June 2007
Posted on: June 27, 2007
Genzyme would like to take this opportunity to provide a brief update to the Pompe patient community regarding the US supply of Myozyme® (alglucosidase alfa). As planned, Genzyme submitted the necessary documentation to the FDA this month for the licensure of the larger scale manufacturing process and continues to anticipate an FDA decision in the fourth quarter of 2007.